Efficacy of CDK4/6 inhibitors (palbociclib, ribociclib and abemaciclib) beyond second line
Latest Information Update: 16 Jun 2020
At a glance
- Drugs Abemaciclib (Primary) ; Palbociclib (Primary) ; Ribociclib (Primary)
- Indications Cancer
- Focus Therapeutic Use
Most Recent Events
- 16 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology